AcuCort AB (publ) (XSAT:ACUC)

AcuCort AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	8.63	7.72	6.59	5.02	3.46	1.53
Revenue Growth (YoY)	23.04%	17.07%	31.24%	45.05%	126.68%	-62.35%
Cost of Revenue	20.65	16.11	15.02	-	-	6.91
Gross Profit	-12.02	-8.39	-8.43	5.02	3.46	-5.38
Selling, General & Admin	5.26	5.32	4.82	3.86	2.83	2.37
Other Operating Expenses	-	-	-	15.99	11.92	-
Operating Expenses	15.18	8.99	4.82	19.85	14.76	2.37
Operating Income	-27.21	-17.39	-13.25	-14.83	-11.3	-7.75
Interest Expense	-0.12	-0.16	-0.73	-0.02	-0.03	-0.02
Interest & Investment Income	0.39	0.15	0.29	0.05	-	-
Pretax Income	-26.93	-17.4	-13.69	-14.79	-11.32	-7.77
Net Income	-26.93	-17.4	-13.69	-14.79	-11.32	-7.77
Net Income to Common	-26.93	-17.4	-13.69	-14.79	-11.32	-7.77
Shares Outstanding (Basic)	172	83	31	31	20	19
Shares Outstanding (Diluted)	172	83	31	31	20	19
Shares Change (YoY)	71.40%	166.25%	-1.11%	61.21%	0.54%	-0.26%
EPS (Basic)	-0.16	-0.21	-0.44	-0.47	-0.58	-0.40
EPS (Diluted)	-0.16	-0.21	-0.44	-0.47	-0.58	-0.40
Gross Margin	-139.38%	-108.76%	-127.81%	100.00%	100.00%	-
Operating Margin	-315.41%	-225.28%	-200.99%	-295.14%	-326.16%	-507.21%
Profit Margin	-312.21%	-225.45%	-207.69%	-294.43%	-326.91%	-508.32%
EBITDA	-	-13.71	-	-	-	-
EBITDA Margin	-	-177.67%	-	-	-	-
D&A For EBITDA	-	3.67	-	-	-	-
EBIT	-27.21	-17.39	-13.25	-14.83	-11.3	-7.75
EBIT Margin	-	-225.28%	-200.99%	-295.14%	-	-
Revenue as Reported	8.63	7.72	6.59	5.02	3.46	1.53

Source: S&P Global Market Intelligence. Standard template. Financial Sources.